Atlas Trials

LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures

Clinical trial NCT02548143 · COMPLETED

Trial details

NCT number
NCT02548143
Sponsor
Laboratoire français de Fractionnement et de Biotechnologies
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hemophilia
Start date
2016-08-25
Primary completion
2017-08-06
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.